Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.

被引：0

作者：

Becker, Michael A. ^{[1
]}

Baraf, Herbert S. B. ^{[2
]}

Yood, Robert A. ^{[3
]}

Dillon, Aileen M. ^{[4
]}

Vazquez-Mellado, Janitzia ^{[5
]}

Ottery, Faith D. ^{[6
]}

Khanna, Dinesh ^{[7
]}

Sundy, John S. ^{[8
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Arthrit Rheumatism Associates, Wheaton, MD USA

[3] Reliant Med Grp, Worcester, MA USA

[4] Kaiser Fdn Hosp, San Francisco, CA USA

[5] Hosp Gen Mexico City, Mexico City, DF, Mexico

[6] Savient Pharmaceut Inc, E Brunswick, NJ USA

[7] Univ Michigan, Ann Arbor, MI 48109 USA

[8] Duke Univ, Med Ctr, Durham, NC USA

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

160

引用

页码：S69 / S70

页数：2

共 50 条

[11] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
Cohen, Stanley
Pablos, Jose L.
Zhang, Nan
Rizzo, Warren
Muller, Gerhard
Padmanaban, Devi
Kivitz, Alan
Matsumoto, Alan K.
Kaur, Primal
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[12] Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Devinsky, Orrin
Nabbout, Rima
Miller, Ian
Laux, Linda
Zolnowska, Marta
Wright, Stephen
Roberts, Claire
EPILEPSIA, 2019, 60 (02) : 294 - 302
[13] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
[14] LONG-TERM PERAMPANEL USE IN OPEN-LABEL EXTENSION STUDIES
Rektor, Ivan
Krauss, Gregory L.
Inoue, Yushi
Kaneko, Sunao
Williams, Betsy
Patten, Anna
Bibbiani, Francesco
Laurenza, Antonio
Wechsler, Robert T.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
[15] A long-term, open-label extension study to investigate the long-term safety of alogliptin in subjects with type 2 diabetes
Smith, N.
Pratley, R.
Wilson, C.
Mekki, Q.
DIABETOLOGIA, 2017, 60 : S357 - S358
[16] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
Gladman, Dafna
Coates, Laura
Mease, Philip
van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Guo, Ying
Besuyen, Robin
Helliwell, Philip
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067
[17] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
Coates, Laura
Mease, Philip
Gladman, Dafna
Van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Gao, Jingjing
Besuyen, Robin
Helliwell, Philip
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[18] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
Ohta, Hiroyoshi
Oka, Hiroshi
Usui, Chie
Ohkura, Masayuki
Suzuki, Makoto
Nishioka, Kusuki
MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
[19] Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial
Papp, Kim
Lebwohl, Mark
Puig, Luis
Zeng, Jiewei
Rubant, Simone
Valdes, Joaquin
Leonardi, Craig
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB17 - AB17
[20] Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
Patel, Anup D.
Mazurkiewicz-Beldzinska, Maria
Chin, Richard F.
Gil-Nagel, Antonio
Gunning, Boudewijn
Halford, Jonathan J.
Mitchell, Wendy
Scott Perry, Michael
Thiele, Elizabeth A.
Weinstock, Arie
Dunayevich, Eduardo
Checketts, Daniel
Devinsky, Orrin
EPILEPSIA, 2021, 62 (09) : 2228 - 2239

← 1 2 3 4 5 →